World Generic Medicines Congress 2016

Start

Wed, 10 Feb 2016, 08:00

End

Thu, 11 Feb 2016, 17:00

WebSite

http://www.healthnetworkcommunications.com/conference/world-generic-medicines-congress-europe/?pk_campaign=Terr-Listing&pk_kwd=Europe&_ga=1.135485362.229930861.1446721486

Venue:

The benefits of generics medicines are well celebrated and demand will remain strong with escalating healthcare costs. However, generic pharmaceuticals will have to continue to overcome barriers including increasing competition, the innovator pipeline crisis and pricing pressure. In the rapidly changing market it is critical to adopt the right business strategy.

The 10th Annual World Generic Medicines Congress is Europe’s premier business event providing a comprehensive review of affordable medicine business strategy. It unites senior executives from the generic and biosimilar industries to provide fresh insights, future market trends, innovative commercial strategies and opportunities for growth for affordable medicines

Exhibit

Symposia

Workshops

Organiser

Sponsor

The 10th World Generic Medicines Congress is the leading generic strategy conference in Europe. Increase your brand awareness and demonstrate thought leadership in front of over 150 senior representatives from generic pharmaceutical companies.

Your opportunity

• Grow long term relationships by arranging meetings with top prospects

• Speak and demonstrate thought leadership

• Increase brand awareness and positioning

Why sponsor

• Generate new business leads and develop relationships

• Build brand presence and raise brand profile

• Showcase latest products and innovations to prospective buyers

• Promote new services to prequalified clientele

• Meet new business partners and suppliers

• Educate pharma and biotech companies

Who will you meet

• Board level and senior representatives from generic pharmaceutical companies

• Investment banks

• Law firms

10 Reasons to Attend

Identify where the generics industry growth opportunities are
Gain an investor’s perspective on the generics market and understand what this means for your business
Hear the latest legal and regulatory developments that will shape your strategy decisions
Explore the growth opportunities of complex generics to strengthen business models
Understand the current market trends and future challenges for biosimilar success
Learn the impact of the current EU & US health policy environment on generic medicines
Interact, debate and discuss the key topics of the generics and biosimilar industry at peer-to-peer roundtable discussions
Discover untapped opportunities in the global market
Collocated with create your own agenda and attend focussed sessions most relevant to your business needs
Network with pioneers, influencers and innovators and return to your company with new ideas and relationships

Booking code	BR03

Package	Before 22nd January 2016	Full price
2 Day conference	£1,495	£1,595

To Register Click Here

World Generic Medicines Congress day 1

08:00	Registration

Generics and Biosimilars Commercial Strategy

08:50	Opening remarks from the chair
09:00	Generics market focus
	Tommy Erdei, Global Joint Head of Pharmaceuticals and Life Sciences, Joint Head of European Healthcare Investment Banking,, Jefferies Group
09:30	Successful strategies to build new business, open up new markets and grow market share in MENA
	Mazen S Darwazeh, Vice Chairman President & CEO MENA & Emerging Markets, Hikma Pharmaceuticals
10:00	The future of the biosimilar industry - mapping the evolution and development of the biosimilar sector
	Mr Sandeep Athalye, Vice President and Head CDMA, Biosimilars, Boehringer Ingelheim
	Mr Bruce Lott, Vice President of State Government Relations, Mylan Inc.
	Dr Cyrus Karkaria, President - Biotechnology, Lupin Pharma
10:45	Speed networking
11:00	Morning refreshments
11:30	Biosimilars - A View From The Capital Markets
	Mr Ashwin Pai, Senior Vice President Healthcare Investment Banking, Jefferies International
12:00	Government affairs affecting the US generics and Biosimilar market
	Mr Bruce Lott, Vice President of State Government Relations, Mylan Inc.
12:30	Lunch
13:30	PEER TO PEER ROUNDTABLES
	Implications of increasing pricing pressure regimes and required market strategies
	Advantages of trade to the generic and biosimilar industry
	Maximising growth opportunities to be gained from fast growing dynamic markets
	What is a sustainable price for a generic and how do you go about achieving it?
	Key Opinion Leader Perspectives and Impact on Adoption Rates for Biosimilars, Pricing Discounts & Rebates
	Trends in Costs and Pricing

Generics
Afternoon Chair: Nitin Naik, Vice President-Global Life Sciences, Frost and Sullivan

15:00	Topic TBC
15:30	Afternoon refreshments
16:00	Role of R&D and niche area expertise
	Dr Deepak Murpani, Global R&D Head, Polpharma
16:30	How smaller generic companies are competing in challenging EU countries
	Ullrich Hanstein, General Manager, Help S.A.
17:00	Closing remarks from the chair
17:05	Drinks party

World Generic Medicines Congress day 2

08:00	Registration
08:50	Opening remarks from the chair
	Mr Simon Cohen, Partner, Taylor Wessing

Generic Market Analysis

09:00	Current themes dominating US Generics
	Ms Apurva Saraf, Vice President - Global Strategy and Corporate Development, Amneal
09:30	Value of Generic Medicines
	Dr Pieter Dylst, Health Economics Officer, E.G.A. European Generic Medicines Association
10:00	The frenzy of M&A in Generics
	Claudio Albrecht, Former CEO and Chairman of the Board of Directors, Actavis Group, Founder and Managing Partner, Albrecht, Prock & Partners AG
10:30	Strategic Marketing: Emerging versus mature markets
	Mr Sameer Agarwal, Senior Vice President-Portfolio & Marketing, Mature & Emerging Markets, Frenesius Kabi
11:00	Morning refreshments

Payer Power

11:30	Purchasing power: how to influence purchasing decisions
	Evert Jan van Lente, Director of EU Affairs, AOK Bundesverdand
12:00	An Industry Observer's Perspective on Cost Containment and Procurement of Generics
	Mr Peter Wittner, Senior Consultant, Interpharm Consultancy
12:30	PANEL DISCUSSION: Trends in pricing and profits
	Frances Cloud, Founder, Pharmacloud Ltd
	Evert Jan van Lente, Director of EU Affairs, AOK Bundesverdand
	Mr Peter Wittner, Senior Consultant, Interpharm Consultancy
13:30	Lunch
14:30	Legal and IP strategies for the generic medicines
	Saufung Ma, Senior Associate, Taylor Wessing
	Mr Simon Cohen, Partner, Taylor Wessing
15:00	Advantages of Trade Policy to the generic and biosimilar industry
	Mr David Jauch, Global Regulatory Affairs and Government Relations Manager, Fresenius Kabi
15:30	Afternoon refreshments
16:00	Updates on health policies
	Juliana Reed, Vice President, Government Affairs, Hospira
16:30	Generics product development from a CDMO perspective
	Reserved for GB Patent
	Mr Antonio Lopez, Director of Business Management for Spain, Portugal and France, Recipharm
	Amine Tahiri, Sales Director South EU, Development & technology, Recipharm
17:00	Closing remarks from the chair